• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Executive Chairman Eberwein Jeffrey E. converted options into 1,914 shares, increasing direct ownership by 0.23% to 818,462 units (SEC Form 4)

    3/27/25 5:08:41 PM ET
    $STRR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $STRR alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Eberwein Jeffrey E.

    (Last) (First) (Middle)
    C/O STAR EQUITY HOLDINGS, INC.
    53 FOREST AVENUE, SUITE 101

    (Street)
    OLD GREENWICH CT 06870

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    STAR EQUITY HOLDINGS, INC. [ STRR ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director X 10% Owner
    X Officer (give title below) Other (specify below)
    Executive Chairman
    3. Date of Earliest Transaction (Month/Day/Year)
    03/27/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 03/27/2025 M 1,914(1) A (2) 818,462(1) D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Restricted Stock Unit (2) 03/27/2025 M 1,914(1) (3) (3) Common Stock 1,914(1) (2) 0 D
    Explanation of Responses:
    1. On June 12, 2024, the Issuer effected a 1-for-5 reverse stock split (the "Reverse Stock Split"). The number of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
    2. Each Restricted Stock Unit represents the right to receive, at settlement, one share of common stock.
    3. On March 27, 2024, the Reporting Person was granted 1,914 Restricted Stock Units (after giving effect to the Reverse Stock Split). As to this grant, one hundred percent (100%) of the Restricted Stock Units vested on March 27, 2025.
    Remarks:
    /s/ Jeffrey E. Eberwein 03/27/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $STRR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $STRR

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $STRR
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Star Equity Holdings and Hudson Global Sign Definitive Merger Agreement

      Accretive Combination Increases Scale, Diversifies Revenue Streams, and Leverages Corporate Overhead and Public Company Costs Better Positions both Companies to Accelerate Growth and Maximize Shareholder Value Companies to Host a Joint Conference Call on May 22 at 10:00 am ET to Discuss the Merger OLD GREENWICH, Conn., May 21, 2025 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. ("Star") (NASDAQ:STRR, STRRP)) and Hudson Global, Inc. ("Hudson") (NASDAQ:HSON) (the "Companies"), announced today the signing of a definitive merger agreement (the "Merger"). Pursuant to the Merger, Star will merge with and into a wholly owned subsidiary of Hudson to form "NewCo". Prior to signing this Merger a

      5/21/25 4:45:03 PM ET
      $HSON
      $STRR
      Professional Services
      Consumer Discretionary
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Star Equity Holdings, Inc. Declares Cash Dividend of $0.25 Per Share of 10% Series A Cumulative Perpetual Preferred Stock

      OLD GREENWICH, Conn., May 20, 2025 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP)) ("Star" or the "Company"), a diversified holding company, announced today that its Board of Directors declared a cash dividend to holders of the Company's 10% Series A Cumulative Perpetual Preferred Stock of $0.25 per share. The record date for this dividend is June 1, 2025, and the payment date is June 10, 2025. About Star Equity Holdings, Inc.Star Equity Holdings, Inc. is a diversified holding company currently composed of three business divisions: Building Solutions, Energy Services, and Investments. Building SolutionsOur Building Solutions division operates in three businesses: (i)

      5/20/25 8:30:43 AM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Star Equity Holdings, Inc. Announces 2025 First Quarter Financial Results

      Q1 2025 revenues increased to $12.9 million vs. $9.1 million in Q1 2024 Alliance Drilling Tools acquisition marks entry into Energy Services Quarter-end Building Solutions backlog stands at record $27.9 million OLD GREENWICH, Conn., May 14, 2025 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP)) ("Star" or the "Company"), a diversified holding company, reported today its financial results for the first quarter (Q1) ended March 31, 2025. All 2025 and 2024 amounts in this release are unaudited. Q1 2025 Financial Highlights vs. Q1 2024 (unaudited) Revenues increased by 41.7% to $12.9 million from $9.1 million.Gross profi

      5/14/25 8:30:04 AM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $STRR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13D/A filed by Star Equity Holdings Inc.

      SC 13D/A - STAR EQUITY HOLDINGS, INC. (0000707388) (Subject)

      9/10/24 4:04:39 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13D/A filed by Star Equity Holdings Inc. (Amendment)

      SC 13D/A - STAR EQUITY HOLDINGS, INC. (0000707388) (Subject)

      9/18/23 4:05:02 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13D/A filed by Star Equity Holdings Inc. (Amendment)

      SC 13D/A - STAR EQUITY HOLDINGS, INC. (0000707388) (Subject)

      8/31/23 5:18:25 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $STRR
    Leadership Updates

    Live Leadership Updates

    See more
    • Star Equity Holdings, Inc. Appoints Rick Coleman as CEO

      OLD GREENWICH, Conn., April 01, 2022 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP))) ("Star Equity" or the "Company"), a diversified holding company, announced today the appointment of Richard ("Rick") K. Coleman, Jr. as Chief Executive Officer, effective April 1, 2022. In addition, Mr. Coleman will be nominated to serve as a director at the Company's upcoming annual meeting of shareholders. Mr. Coleman is a seasoned executive who brings to Star Equity extensive CEO leadership and board-level experience with numerous public and private companies. He was appointed as Star Equity's Chief Operating Officer in January 2022 and has provided valuable insights and direction

      4/1/22 8:00:00 AM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Star Equity Holdings, Inc. Adds Richard Coleman as Chief Operating Officer

      OLD GREENWICH, Conn., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP))) ("Star Equity" or the "Company"), a diversified holding company, announced today the appointment of Richard K. Coleman, Jr. ("Rick") as Chief Operating Officer, effective January 1, 2022. Coleman's addition increases the capacity of Star Equity's senior leadership team. In this role, he will oversee the Company's operations, assist its business leaders in achieving their growth and profitability goals, launch new business initiatives, as well as help analyze and integrate future acquisitions. Coleman brings more than 30 years of executive leadership experience with extensive expertis

      12/20/21 8:00:00 AM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Star Equity Holdings, Inc. Appoints John Gildea to its Board of Directors

      OLD GREENWICH, Conn., Aug. 06, 2021 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP))) ("Star Equity" or the "Company"), a diversified, multi-industry holding company with three business divisions, Healthcare, Construction, and Investments, announced today the appointment of John W. Gildea to its Board of Directors, effective immediately. Mr. Gildea's appointment as independent director expands Star Equity's Board to six members. Mr. Gildea will also serve on the Audit Committee. Mr. Gildea brings over three decades of experience investing in special situation debt and equity of small to middle market companies. He is the founding partner of Gildea Management Co., a fir

      8/6/21 4:38:13 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $STRR
    Financials

    Live finance-specific insights

    See more
    • Star Equity Holdings and Hudson Global Sign Definitive Merger Agreement

      Accretive Combination Increases Scale, Diversifies Revenue Streams, and Leverages Corporate Overhead and Public Company Costs Better Positions both Companies to Accelerate Growth and Maximize Shareholder Value Companies to Host a Joint Conference Call on May 22 at 10:00 am ET to Discuss the Merger OLD GREENWICH, Conn., May 21, 2025 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. ("Star") (NASDAQ:STRR, STRRP)) and Hudson Global, Inc. ("Hudson") (NASDAQ:HSON) (the "Companies"), announced today the signing of a definitive merger agreement (the "Merger"). Pursuant to the Merger, Star will merge with and into a wholly owned subsidiary of Hudson to form "NewCo". Prior to signing this Merger a

      5/21/25 4:45:03 PM ET
      $HSON
      $STRR
      Professional Services
      Consumer Discretionary
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Star Equity Holdings, Inc. Declares Cash Dividend of $0.25 Per Share of 10% Series A Cumulative Perpetual Preferred Stock

      OLD GREENWICH, Conn., May 20, 2025 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP)) ("Star" or the "Company"), a diversified holding company, announced today that its Board of Directors declared a cash dividend to holders of the Company's 10% Series A Cumulative Perpetual Preferred Stock of $0.25 per share. The record date for this dividend is June 1, 2025, and the payment date is June 10, 2025. About Star Equity Holdings, Inc.Star Equity Holdings, Inc. is a diversified holding company currently composed of three business divisions: Building Solutions, Energy Services, and Investments. Building SolutionsOur Building Solutions division operates in three businesses: (i)

      5/20/25 8:30:43 AM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Star Equity Holdings, Inc. Announces 2025 First Quarter Financial Results

      Q1 2025 revenues increased to $12.9 million vs. $9.1 million in Q1 2024 Alliance Drilling Tools acquisition marks entry into Energy Services Quarter-end Building Solutions backlog stands at record $27.9 million OLD GREENWICH, Conn., May 14, 2025 (GLOBE NEWSWIRE) -- Star Equity Holdings, Inc. (NASDAQ:STRR, STRRP)) ("Star" or the "Company"), a diversified holding company, reported today its financial results for the first quarter (Q1) ended March 31, 2025. All 2025 and 2024 amounts in this release are unaudited. Q1 2025 Financial Highlights vs. Q1 2024 (unaudited) Revenues increased by 41.7% to $12.9 million from $9.1 million.Gross profi

      5/14/25 8:30:04 AM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $STRR
    SEC Filings

    See more
    • SEC Form 425 filed by Star Equity Holdings Inc.

      425 - STAR EQUITY HOLDINGS, INC. (0000707388) (Subject)

      5/21/25 9:44:38 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Star Equity Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure

      8-K - STAR EQUITY HOLDINGS, INC. (0000707388) (Filer)

      5/21/25 9:40:28 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Star Equity Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - STAR EQUITY HOLDINGS, INC. (0000707388) (Filer)

      5/20/25 4:09:26 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $STRR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Coleman Richard Kenneth Jr. bought $10,675 worth of shares (2,500 units at $4.27) and bought $4,925 worth of 10% Series A Cumulative Perpetual Preferred Stock (500 units at $9.85), decreasing direct ownership by 93% to 2,500 units (SEC Form 4)

      4 - STAR EQUITY HOLDINGS, INC. (0000707388) (Issuer)

      8/20/24 4:10:35 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Butcher Thatcher bought $3,120 worth of shares (3,000 units at $1.04), increasing direct ownership by 100% to 6,000 units (SEC Form 4)

      4 - STAR EQUITY HOLDINGS, INC. (0000707388) (Issuer)

      12/15/23 1:41:36 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Coleman Richard Kenneth Jr. bought $2,220 worth of shares (2,000 units at $1.11) and bought $18,900 worth of 10% Series A Cumulative Perpetual Preferred Stock (2,000 units at $9.45), decreasing direct ownership by 98% to 2,000 units (SEC Form 4)

      4 - STAR EQUITY HOLDINGS, INC. (0000707388) (Issuer)

      12/4/23 8:25:38 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $STRR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Parks Louis A.

      4 - STAR EQUITY HOLDINGS, INC. (0000707388) (Issuer)

      5/21/25 4:14:38 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 4 filed by Executive Chairman Eberwein Jeffrey E.

      4 - STAR EQUITY HOLDINGS, INC. (0000707388) (Issuer)

      5/21/25 4:13:02 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 4 filed by Director Palmer Jennifer

      4 - STAR EQUITY HOLDINGS, INC. (0000707388) (Issuer)

      5/21/25 4:11:19 PM ET
      $STRR
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care